Pharmacokinetics of Haloperidol

@article{Kudo1999PharmacokineticsOH,
  title={Pharmacokinetics of Haloperidol},
  author={Shoji Kudo and Takashi Ishizaki},
  journal={Clinical Pharmacokinetics},
  year={1999},
  volume={37},
  pages={435-456}
}
  • S. Kudo, T. Ishizaki
  • Published 1 December 1999
  • Biology, Medicine, Psychology, Chemistry
  • Clinical Pharmacokinetics
AbstractHaloperidol is commonly used in the therapy of patients with acute and chronic schizophrenia. The enzymes involved in the biotransformation of haloperidol include cytochrome P450 (CYP), carbonyl reductase and uridine diphosphoglucose glucuronosyltransferase.The greatest proportion of the intrinsic hepatic clearance of haloperidol is by glucuronidation, followed by the reduction of haloperidol to reduced haloperidol and by CYP-mediated oxidation. In studies of CYP-mediated disposition in… 
Effects of haloperidol and its pyridinium metabolite on plasma membrane permeability and fluidity in the rat brain
Mechanism of Action of Antipsychotics, Haloperidol and Olanzapine in vitro
TLDR
Cell death in PC-12 pheochromocytoma cells exposed to HP or Olz may primarily be necrotic in nature, rather than apoptotic, and secondary effects manifested in patients with chronic treatment with HP may, at least in part, be attributed to the pro-oxidant effects of the drug.
Involvement of microsomal NADPH-cytochrome P450 reductase in metabolic reduction of drug ketones.
TLDR
It can be concluded that microsomal NADPH-cytochrome P450 reductase can contribute to metabolic keto reductions in xenobiotics, since microsomes also catalysed these carbonyl reductions to some extent.
Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects.
Effects of treatment with haloperidol and clozapine on the plasma concentrations of thyroid hormones in rats
TLDR
The results indicate that antipsychotic treatment can contribute to the thyroid dysfunction, and greater caution should be applied to the antipsychotics use.
Glucuronidation enzymes, genes and psychiatry.
TLDR
The importance of glucuronidation and the implications for psychiatry is illustrated as UGTs appear to be in small concentrations in brain tissue (and higher concentrations at brain capillaries).
Effect of herbal and nutritional products on the central nervous system effects of haloperidol: a systematic review
TLDR
It is advised to monitor the potential risk of interactions between haloperidol and co-administrated HNPs in clinical practice, and consider factors such as modulations on oxidative stress and dopaminergic pathway were proposed.
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
TLDR
There is a considerable variability in the CYP2D6 allele distribution among different ethnic groups, resulting in variable percentages of PMs, IMs, EMs and UMs in a given population and the number of alleles is still growing.
Interactions between Antiepileptic and Antipsychotic Drugs
TLDR
A review of human clinical data on the interactions between the antiepileptic drugs carbamazepine, valproic acid (sodium valproate), vigabatrin, lamotrigine, gabapentin, topiramate, tiagabine, oxcarbazepines, levetiracetam, pregabalin, felbamate, zonisamide, phenobarbital and phenytoin is presented.
...
...

References

SHOWING 1-10 OF 194 REFERENCES
Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite.
Evidence that partially oxidized piperidine derivatives such as the Parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are biotransformed in a reaction catalyzed by
Pharmacokinetics of Haloperidol
TLDR
It appears that a plasma haloperidol concentration range of 4 µg/L to an upper limit of 20 to 25 µG/L produces therapeutic response, and the role of reduced haloperIDol in determining clinical response is not clear.
Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro
TLDR
Fluvoxamine is a fairly potent inhibitor of CYP2C19 and it has the potential for causing drug-drug interactions with substrates for CYP 2C19 such as imipramine, clomipramines, amitriptyline and diazepam.
Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy.
TLDR
The results indicate that at concentrations of carbamazepine which produce marked induction of hepatic CYP3A, an enzyme involved in the metabolism and bioactivation of carbazepine, there is only a slight increase in lymphocyte microsomal epoxide hydrolase.
Pharmacokinetic Interactions Between Antiepileptic Drugs
TLDR
Antiepileptic drug interactions represent a common clinical problem which has been compounded by the introduction of many new compounds in recent years, and some need only careful clinical monitoring, but others require prompt dosage adjustment.
Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
TLDR
Glucuronidation of HAL is the major metabolic pathway of HAL in humans and its activity is important in determining steady-state plasma HAL concentrations, which may also be a major contributing factor in the interindividual variability of HAL metabolism.
Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers.
TLDR
The plasma levels of the reduced metabolite of haloperidol, after a single 2- or 4-mg oral dose of the parent drug, are significantly higher in PM than in EM of debrisoquine.
Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype.
TLDR
PM of debrisoquine (7% of Caucasian populations) might, therefore, on common doses of haloperidol, achieve high plasma concentrations and thereby have an increased risk of side effects and at the other extreme, very rapid metabolizers may need increased doses of Haloperidols.
Inhibition by fluoxetine of cytochrome P450 2D6 activity
TLDR
Inhibition of CYP2D6 activity in patients undergoing treatment with fluoxetine or other serotonin uptake inhibitors could contribute to toxicity or attenuated response from concurrent medications that are substrates of this enzyme.
Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.
TLDR
The induction of the sulphoxidation of omeprazole by CBZ seems to have no major clinical implication, and the ratio of the AUCs of omEPrazole and its sulphone, used as an index of CYP3A4 activity, decreased in all patients.
...
...